Joaquin Duato said finding a cure for certain cancers and turning others into chronic diseases is an achievable target for ...

Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the ...

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.

The diversification king . Johnson & Johnson is one of the more diversified healthcare stocks on the market. The company's business spans pharmaceuticals and medical devices. With ...

J&J generates over $20 billion of free cash flow per year, which allows the company to reinvest in the business and return ...

Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website​ on Friday, CBS News exclusively learned.

Friday's verdict comes after a month-long trial combining the cases of three women who died of ovarian cancer that their ...

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and AbbVie (NYSE:ABBV) both posted Q1 2026 results that beat revenue expectations and prompted raised full-year guidance. JNJ leaned on a ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els ...

On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one ...